Utah has launched a pilot program allowing residents to refill prescriptions via an AI chatbot named Doctronic. The initiative operates within a “regulatory sandbox,” bypassing traditional state medical licensing laws. While proponents view this as a convenience-driven evolution of healthcare, critics including state medical board officials warn of significant safety risks, particularly regarding medications like … Read more
The Fast Track to Healing: How Regulatory Shifts are Redefining Modern Medicine For decades, the journey from a laboratory breakthrough to a patient’s bedside has been a grueling marathon of red tape, clinical trials, and administrative bottlenecks. However, we are entering an era where the philosophy of healthcare regulation is shifting from “caution at all … Read more
North Carolina Secures $11 Million Settlement with EpiPen Manufacturer North Carolina Attorney General Jeff Jackson and State Treasurer Brad Briner announced a settlement with EpiPen manufacturer Viatris (formerly Mylan) on Thursday, securing $11 million for the state. The agreement addresses allegations of anti-competitive practices that led to significant price increases for the life-saving allergy medication. … Read more
Breast Cancer Drug Shows Promise in Boosting IVF Success Rates Hopeful parents facing fertility challenges may have a new ally: letrozole, a widely used breast cancer drug. Recent research indicates that adding letrozole to standard IVF hormone protocols could significantly improve outcomes, particularly for women with diminished ovarian reserve. The Rising Need for IVF and … Read more
The Unexpected Lifeline for Rural Pharmacies: From Prescriptions to Pastures Crystal McEntire embodies a growing trend in rural Texas: the diversification of small businesses to survive economic headwinds. As the owner of two pharmacies in Wheeler County, she found herself increasingly reliant on her family’s Red Angus cattle ranch, McEntire Red Angus, to maintain her … Read more
Healthcare in 2026: Navigating Rising Costs and Emerging Trends Healthcare affordability is a growing concern for Americans, consistently ranking as a top financial worry. As we move deeper into 2026, several key trends are poised to reshape the healthcare landscape, impacting access and affordability for individuals and families. The Pressure of Rising Premiums and Deductibles … Read more
ACA Marketplace Faces Headwinds: Rising Costs and Shifting Enrollment The Affordable Care Act (ACA) Marketplace is navigating a challenging landscape as the expiration of enhanced premium tax credits sends shockwaves through enrollment and affordability. A recent follow-up survey by KFF reveals a significant increase in costs for many enrollees, leading to difficult choices and a … Read more
India’s Ozempic Revolution: Will Cheaper Weight Loss Drugs Reach US Shores? The global weight-loss landscape is on the cusp of a dramatic shift. This weekend marks a pivotal moment as Indian pharmaceutical companies gain the green light to manufacture and sell generic versions of Ozempic and Wegovy, the blockbuster drugs transforming diabetes and obesity treatment. … Read more
Medicaid Drug Spending: Navigating Rising Costs and New Federal Initiatives Medicaid prescription drug spending has seen substantial growth in recent years, fueled by both the emergence of innovative, high-cost medications – including GLP-1s and cell and gene therapies – and overall increases in healthcare utilization. While rebates help offset these costs, the landscape is shifting … Read more
Public Worry Over Drug Costs Reaches New Heights, Bipartisan Support for Regulation Grows A new KFF Health Tracking Poll reveals a growing sense of anxiety among Americans regarding the affordability of prescription medications. As the Trump administration pushes its new TrumpRx website, a majority – 59% – express concern about being able to afford the … Read more